Anh D Ngo1, Christine L Roberts2, Jian Sheng Chen2, Gemma Figtree3. 1. Clinical and Population Perinatal Health Research, Kolling Institute of Medical Research, University of Sydney at Royal North Shore Hospital, St Leonards, New South Wales, Australia. Electronic address: anh.ngo@sydney.edu.au. 2. Clinical and Population Perinatal Health Research, Kolling Institute of Medical Research, University of Sydney at Royal North Shore Hospital, St Leonards, New South Wales, Australia. 3. Department of Cardiology, Royal North Shore Hospital, St Leonards, New South Wales, Australia.
Abstract
BACKGROUND: Delivery of small for gestational age (SGA) infants has been associated with increased risk of future maternal cardiovascular disease (CVD). However, whether the risk increases progressively with the greater severity of SGA and number of SGA infants has not been explored. METHODS: A population-based record linkage study was conducted among 812,732 women delivering live born, singleton infants at term between 1994 and 2011 in New South Wales, Australia. Birth records were linked to the mothers' subsequent hospitalisation or death records to identify CVD events (coronary heart disease, cerebrovascular events, and chronic heart failure) after a median of 7.4 years. Cox proportional hazard regression was used to estimate adjusted hazard ratios (AHR) [95% confidence interval (CI)] for the associations between the severity (moderate or extreme) of SGA and number of SGA infants and subsequent risk of maternal CVD, accounting for maternal age at last birth, socioeconomic status, parity, smoking, (pre-gestational and gestational) diabetes, and (chronic and pregnancy) hypertension. RESULTS: Compared to mothers of non-SGA infants, AHRs [95%CI] of CVD among mothers of moderately and extremely SGA infants were 1.36 [1.23-1.49], and 1.66 [1.47-1.87], respectively, while AHRs among mothers with 1, 2, and ≥3 SGA infants were 1.42 [1.30-1.54], 1.65 [1.34-2.03], and 2.42 [1.52-3.85], respectively, indicating a dose-response relationship. AHRs of specific CVD categories showed a similar pattern. CONCLUSIONS: Delivery of an SGA infant was associated with a dose-dependent increase in the risk of maternal CVD according to both the severity of SGA and number of previous SGA infants.
BACKGROUND: Delivery of small for gestational age (SGA) infants has been associated with increased risk of future maternal cardiovascular disease (CVD). However, whether the risk increases progressively with the greater severity of SGA and number of SGA infants has not been explored. METHODS: A population-based record linkage study was conducted among 812,732 women delivering live born, singleton infants at term between 1994 and 2011 in New South Wales, Australia. Birth records were linked to the mothers' subsequent hospitalisation or death records to identify CVD events (coronary heart disease, cerebrovascular events, and chronic heart failure) after a median of 7.4 years. Cox proportional hazard regression was used to estimate adjusted hazard ratios (AHR) [95% confidence interval (CI)] for the associations between the severity (moderate or extreme) of SGA and number of SGA infants and subsequent risk of maternal CVD, accounting for maternal age at last birth, socioeconomic status, parity, smoking, (pre-gestational and gestational) diabetes, and (chronic and pregnancy) hypertension. RESULTS: Compared to mothers of non-SGA infants, AHRs [95%CI] of CVD among mothers of moderately and extremely SGA infants were 1.36 [1.23-1.49], and 1.66 [1.47-1.87], respectively, while AHRs among mothers with 1, 2, and ≥3 SGA infants were 1.42 [1.30-1.54], 1.65 [1.34-2.03], and 2.42 [1.52-3.85], respectively, indicating a dose-response relationship. AHRs of specific CVD categories showed a similar pattern. CONCLUSIONS: Delivery of an SGA infant was associated with a dose-dependent increase in the risk of maternal CVD according to both the severity of SGA and number of previous SGA infants.
Authors: Yamnia I Cortés; Janet M Catov; Maria Brooks; Siobán D Harlow; Carmen R Isasi; Elizabeth A Jackson; Karen A Matthews; Rebecca C Thurston; Emma Barinas-Mitchell Journal: J Am Heart Assoc Date: 2017-12-29 Impact factor: 5.501
Authors: Samantha M Garay; Katrina A Savory; Lorna Sumption; Richard Penketh; Anna B Janssen; Rosalind M John Journal: PLoS One Date: 2019-03-12 Impact factor: 3.240
Authors: Samantha M Garay; Katrina A Savory; Lorna A Sumption; Richard J A Penketh; Ian R Jones; Anna B Janssen; Rosalind M John Journal: Psychoneuroendocrinology Date: 2019-05-31 Impact factor: 4.905
Authors: Emily Aldridge; Maleesa Pathirana; Melanie Wittwer; Susan Sierp; Shalem Y Leemaqz; Claire T Roberts; Gustaaf A Dekker; Margaret A Arstall Journal: Front Cardiovasc Med Date: 2022-03-14
Authors: Emily Aldridge; Maleesa Pathirana; Melanie Wittwer; Susan Sierp; Shalem Y Leemaqz; Claire T Roberts; Gustaaf A Dekker; Margaret A Arstall Journal: Diabetol Metab Syndr Date: 2022-10-06 Impact factor: 5.395
Authors: Grace M Egeland; Svetlana Skurtveit; Anne Cathrine Staff; Geir Egil Eide; Anne-Kjersti Daltveit; Kari Klungsøyr; Lill Trogstad; Per M Magnus; Anne Lise Brantsæter; Margaretha Haugen Journal: J Am Heart Assoc Date: 2018-05-13 Impact factor: 5.501